Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-039819
Date:2021-06-09
Issuer: NEOLEUKIN THERAPEUTICS, INC. (NLTX)
Original Submission Date:

Reporting Person:

WALKEY CARL
CO NEOLEUKIN THERAPEUTICS, INC.
188 EAST BLAINE STREET, #450 SEATTLE, WA 98102

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-09 S 650 d $10.82 1,353,089 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 this transaction was effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person.
f2 represents the weighted average sale price. the lowest price at which shares were sold was $10.81 and the highest price at which shares were sold was $11.00. the reporting person undertakes to provide upon request to the staff of the securities and exchange commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
WhaleWisdom Logo

Elevate your investments